ClinicalTrials.gov
ClinicalTrials.gov Menu

Reducing Barriers to Drug Abuse Treatment Services (RBP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00273845
Recruitment Status : Completed
First Posted : January 9, 2006
Last Update Posted : February 24, 2009
Sponsor:
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by:
Wright State University

Brief Summary:
The broad goal of this study is to assess the effectiveness of two interventions to facilitate treatment linkage and treatment engagement. "Treatment linkage" is operationally defined as completion of agency intake procedures and attendance at the first clinical or therapy session. "Treatment engagement" represents a more comprehensive conceptualization of "treatment retention" and includes measures of the clinical and ancillary services actually received by the client over time; as such, client engagement focuses on the intensity and duration of treatment participation. This study will enhance the CIU concept by conducting a controlled trial, using a three-armed research design, of interventions designed to enhance treatment linkage and treatment engagement. These interventions - a Motivational Intervention and Strengths-Based Case Management - are science-based and have demonstrated efficacy in moving drug abusers towards treatment and supporting treatment engagement.

Condition or disease Intervention/treatment Phase
Substance Abuse Behavioral: Motivational interviewing Behavioral: Strengths-Based Case Management Phase 2 Phase 3

Detailed Description:

The Specific Aims of the project are:

  1. To conduct a detailed qualitative/ethnographic investigation to study: (a) the processes and factors operant in a person's decision to link with a substance abuse treatment agency once a formal (i.e., professional) assessment and referral have been made; and (b) the processes and factors operant in staying in treatment once it has been initiated.
  2. To identify and classify, using quantitative methods, the operant barriers to treatment linkage and engagement. We will assess the factors that are associated with these barriers and examine the effects of the study's interventions on removing them.
  3. To evaluate the effectiveness, using a controlled trial, of a Motivational Intervention and Strengths-Based Case Management, compared to the CIU's "standard" referral process, by examining differences between the Standard, Motivational Intervention, and Case Management conditions on treatment linkage and engagement outcomes. The conceptual framework for this controlled trial is the well-studied Andersen model of access and health service use, modified for chemical dependency services (Andersen, 1995). The interventions are designed to affect mutable factors such as perceived barriers to treatment. Data will be collected at baseline, and at 3 and 6 months thereafter. Analyses will examine whether the interventions work better with different groups of clients (e.g. cocaine users versus marijuana users, males versus females, different ethnicities, etc); as well as different treatment modalities (standard outpatient versus intensive outpatient.)
  4. To conduct a quantitative investigation of the effects of Individual Level and Health Care System Level factors that predict treatment linkage and engagement in the context of the proposed interventions. This study component will develop comprehensive models to predict how these factors interact with the study's interventions to effect treatment linkage and treatment engagement.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 678 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Reducing Barriers to Drug Abuse Treatment Services
Study Start Date : May 2003
Actual Primary Completion Date : May 2008
Actual Study Completion Date : May 2008

Arm Intervention/treatment
Experimental: 1
One session of motivational interviewing
Behavioral: Motivational interviewing
One session

Experimental: 2
Five sessions of strengths-based case management
Behavioral: Strengths-Based Case Management
5 sessions




Primary Outcome Measures :
  1. Linkage and Retention in substance abuse treatment [ Time Frame: 3 months, 6 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • substance abuse or dependence per DSM-IVR criteria

Exclusion Criteria:

  • active thought disorder

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00273845


Locations
United States, Ohio
Samaritan CrisisCare
Dayton, Ohio, United States, 45345
Sponsors and Collaborators
Wright State University
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: Richard C Rapp, M.S.W. Boonshoft School of Medicine, Wright State University

Responsible Party: Marianne Shreck, Wright State University
ClinicalTrials.gov Identifier: NCT00273845     History of Changes
Other Study ID Numbers: 02-407-10
1R01DA015690 ( U.S. NIH Grant/Contract )
HSP 2527
First Posted: January 9, 2006    Key Record Dates
Last Update Posted: February 24, 2009
Last Verified: February 2009

Keywords provided by Wright State University:
case management
substance abuse treatment
linkage

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders